nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—PTGS1—Bortezomib—hematologic cancer	0.0433	0.0737	CbGbCtD
Eszopiclone—PTGS1—Thalidomide—hematologic cancer	0.0377	0.0642	CbGbCtD
Eszopiclone—PTGS1—Ifosfamide—hematologic cancer	0.0332	0.0565	CbGbCtD
Eszopiclone—PTGS1—Imatinib—hematologic cancer	0.0317	0.054	CbGbCtD
Eszopiclone—CYP2C9—Bexarotene—hematologic cancer	0.0284	0.0484	CbGbCtD
Eszopiclone—CYP2C8—Bortezomib—hematologic cancer	0.025	0.0425	CbGbCtD
Eszopiclone—CYP2C9—Idarubicin—hematologic cancer	0.0236	0.0401	CbGbCtD
Eszopiclone—CYP2C8—Ifosfamide—hematologic cancer	0.0192	0.0326	CbGbCtD
Eszopiclone—CYP2C9—Bortezomib—hematologic cancer	0.0174	0.0297	CbGbCtD
Eszopiclone—CYP2C8—Nilotinib—hematologic cancer	0.0166	0.0283	CbGbCtD
Eszopiclone—CYP3A4—Bexarotene—hematologic cancer	0.0165	0.0282	CbGbCtD
Eszopiclone—PTGS1—Etoposide—hematologic cancer	0.0159	0.027	CbGbCtD
Eszopiclone—CYP3A4—Lomustine—hematologic cancer	0.0154	0.0262	CbGbCtD
Eszopiclone—CYP3A4—Busulfan—hematologic cancer	0.0154	0.0262	CbGbCtD
Eszopiclone—CYP2C9—Thalidomide—hematologic cancer	0.0152	0.0259	CbGbCtD
Eszopiclone—CYP2C9—Teniposide—hematologic cancer	0.0145	0.0247	CbGbCtD
Eszopiclone—CYP3A4—Thiotepa—hematologic cancer	0.0137	0.0233	CbGbCtD
Eszopiclone—CYP2C9—Ifosfamide—hematologic cancer	0.0134	0.0228	CbGbCtD
Eszopiclone—CYP2C9—Imatinib—hematologic cancer	0.0128	0.0217	CbGbCtD
Eszopiclone—CYP2C9—Nilotinib—hematologic cancer	0.0116	0.0198	CbGbCtD
Eszopiclone—CYP3A4—Methoxsalen—hematologic cancer	0.0107	0.0181	CbGbCtD
Eszopiclone—CYP3A4—Bortezomib—hematologic cancer	0.0101	0.0173	CbGbCtD
Eszopiclone—CYP3A4—Daunorubicin—hematologic cancer	0.0097	0.0165	CbGbCtD
Eszopiclone—CYP2C8—Etoposide—hematologic cancer	0.00916	0.0156	CbGbCtD
Eszopiclone—CYP3A4—Cytarabine—hematologic cancer	0.00855	0.0146	CbGbCtD
Eszopiclone—CYP3A4—Teniposide—hematologic cancer	0.00843	0.0143	CbGbCtD
Eszopiclone—CYP3A4—Ifosfamide—hematologic cancer	0.00778	0.0132	CbGbCtD
Eszopiclone—CYP2C8—Dexamethasone—hematologic cancer	0.00753	0.0128	CbGbCtD
Eszopiclone—CYP3A4—Imatinib—hematologic cancer	0.00743	0.0126	CbGbCtD
Eszopiclone—CYP3A4—Ruxolitinib—hematologic cancer	0.00699	0.0119	CbGbCtD
Eszopiclone—CYP3A4—Nilotinib—hematologic cancer	0.00675	0.0115	CbGbCtD
Eszopiclone—CYP3A4—Vinorelbine—hematologic cancer	0.00669	0.0114	CbGbCtD
Eszopiclone—CYP2C9—Cisplatin—hematologic cancer	0.0065	0.0111	CbGbCtD
Eszopiclone—CYP3A4—Triamcinolone—hematologic cancer	0.00612	0.0104	CbGbCtD
Eszopiclone—CYP3A4—Dasatinib—hematologic cancer	0.00597	0.0102	CbGbCtD
Eszopiclone—CYP3A4—Mitoxantrone—hematologic cancer	0.00589	0.01	CbGbCtD
Eszopiclone—CYP2C9—Dexamethasone—hematologic cancer	0.00525	0.00894	CbGbCtD
Eszopiclone—CYP3A4—Betamethasone—hematologic cancer	0.00525	0.00894	CbGbCtD
Eszopiclone—CYP3A4—Prednisolone—hematologic cancer	0.00518	0.00882	CbGbCtD
Eszopiclone—CYP3A4—Prednisone—hematologic cancer	0.00489	0.00833	CbGbCtD
Eszopiclone—CYP3A4—Irinotecan—hematologic cancer	0.00464	0.0079	CbGbCtD
Eszopiclone—CYP3A4—Vinblastine—hematologic cancer	0.00412	0.00702	CbGbCtD
Eszopiclone—CYP3A4—Vincristine—hematologic cancer	0.00406	0.0069	CbGbCtD
Eszopiclone—CYP3A4—Etoposide—hematologic cancer	0.00372	0.00632	CbGbCtD
Eszopiclone—CYP3A4—Dexamethasone—hematologic cancer	0.00306	0.0052	CbGbCtD
Eszopiclone—CYP3A4—Doxorubicin—hematologic cancer	0.00253	0.00431	CbGbCtD
Eszopiclone—GABRG3—testis—hematologic cancer	0.00045	0.0783	CbGeAlD
Eszopiclone—TSPO—hematopoietic system—hematologic cancer	0.000406	0.0705	CbGeAlD
Eszopiclone—GABRA5—testis—hematologic cancer	0.000346	0.0602	CbGeAlD
Eszopiclone—GABRA3—testis—hematologic cancer	0.000322	0.056	CbGeAlD
Eszopiclone—TSPO—gonad—hematologic cancer	0.000308	0.0536	CbGeAlD
Eszopiclone—GABRB2—lung—hematologic cancer	0.000279	0.0484	CbGeAlD
Eszopiclone—CYP2C8—hematopoietic system—hematologic cancer	0.000278	0.0484	CbGeAlD
Eszopiclone—TSPO—blood—hematologic cancer	0.000269	0.0467	CbGeAlD
Eszopiclone—GABRB2—testis—hematologic cancer	0.000263	0.0457	CbGeAlD
Eszopiclone—TSPO—bone marrow—hematologic cancer	0.00026	0.0452	CbGeAlD
Eszopiclone—CYP2C9—hematopoietic system—hematologic cancer	0.000247	0.043	CbGeAlD
Eszopiclone—TSPO—lung—hematologic cancer	0.000236	0.0409	CbGeAlD
Eszopiclone—PTGS1—hematopoietic system—hematologic cancer	0.000226	0.0392	CbGeAlD
Eszopiclone—TSPO—testis—hematologic cancer	0.000222	0.0386	CbGeAlD
Eszopiclone—CYP3A4—hematopoietic system—hematologic cancer	0.000189	0.0328	CbGeAlD
Eszopiclone—CYP2C8—blood—hematologic cancer	0.000184	0.032	CbGeAlD
Eszopiclone—GABRA2—lymph node—hematologic cancer	0.000174	0.0302	CbGeAlD
Eszopiclone—CYP2C9—blood—hematologic cancer	0.000164	0.0285	CbGeAlD
Eszopiclone—TSPO—lymph node—hematologic cancer	0.000161	0.028	CbGeAlD
Eszopiclone—CYP2C8—testis—hematologic cancer	0.000153	0.0265	CbGeAlD
Eszopiclone—PTGS1—blood—hematologic cancer	0.00015	0.026	CbGeAlD
Eszopiclone—PTGS1—lung—hematologic cancer	0.000131	0.0228	CbGeAlD
Eszopiclone—CYP3A4—blood—hematologic cancer	0.000125	0.0217	CbGeAlD
Eszopiclone—PTGS1—testis—hematologic cancer	0.000124	0.0215	CbGeAlD
Eszopiclone—PTGS1—lymph node—hematologic cancer	8.97e-05	0.0156	CbGeAlD
Eszopiclone—Hypersensitivity—Prednisolone—hematologic cancer	3.09e-05	8.74e-05	CcSEcCtD
Eszopiclone—Hypoaesthesia—Doxorubicin—hematologic cancer	3.08e-05	8.74e-05	CcSEcCtD
Eszopiclone—Pharyngitis—Doxorubicin—hematologic cancer	3.08e-05	8.71e-05	CcSEcCtD
Eszopiclone—Dyspepsia—Dexamethasone—hematologic cancer	3.08e-05	8.71e-05	CcSEcCtD
Eszopiclone—Dyspepsia—Betamethasone—hematologic cancer	3.08e-05	8.71e-05	CcSEcCtD
Eszopiclone—Urticaria—Triamcinolone—hematologic cancer	3.06e-05	8.67e-05	CcSEcCtD
Eszopiclone—Oedema peripheral—Doxorubicin—hematologic cancer	3.05e-05	8.65e-05	CcSEcCtD
Eszopiclone—Dysgeusia—Methotrexate—hematologic cancer	3.05e-05	8.64e-05	CcSEcCtD
Eszopiclone—Asthenia—Etoposide—hematologic cancer	3.05e-05	8.63e-05	CcSEcCtD
Eszopiclone—Body temperature increased—Triamcinolone—hematologic cancer	3.04e-05	8.62e-05	CcSEcCtD
Eszopiclone—Anaphylactic shock—Prednisone—hematologic cancer	3.04e-05	8.62e-05	CcSEcCtD
Eszopiclone—Decreased appetite—Betamethasone—hematologic cancer	3.04e-05	8.6e-05	CcSEcCtD
Eszopiclone—Decreased appetite—Dexamethasone—hematologic cancer	3.04e-05	8.6e-05	CcSEcCtD
Eszopiclone—Nausea—Mitoxantrone—hematologic cancer	3.03e-05	8.59e-05	CcSEcCtD
Eszopiclone—Nausea—Irinotecan—hematologic cancer	3.03e-05	8.59e-05	CcSEcCtD
Eszopiclone—Infection—Prednisone—hematologic cancer	3.02e-05	8.56e-05	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.02e-05	8.54e-05	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.02e-05	8.54e-05	CcSEcCtD
Eszopiclone—Back pain—Methotrexate—hematologic cancer	3.01e-05	8.54e-05	CcSEcCtD
Eszopiclone—Fatigue—Dexamethasone—hematologic cancer	3.01e-05	8.53e-05	CcSEcCtD
Eszopiclone—Fatigue—Betamethasone—hematologic cancer	3.01e-05	8.53e-05	CcSEcCtD
Eszopiclone—Chills—Epirubicin—hematologic cancer	3.01e-05	8.51e-05	CcSEcCtD
Eszopiclone—Pruritus—Etoposide—hematologic cancer	3e-05	8.51e-05	CcSEcCtD
Eszopiclone—Pain—Dexamethasone—hematologic cancer	2.99e-05	8.46e-05	CcSEcCtD
Eszopiclone—Pain—Betamethasone—hematologic cancer	2.99e-05	8.46e-05	CcSEcCtD
Eszopiclone—Tachycardia—Prednisone—hematologic cancer	2.97e-05	8.41e-05	CcSEcCtD
Eszopiclone—Alopecia—Epirubicin—hematologic cancer	2.96e-05	8.38e-05	CcSEcCtD
Eszopiclone—Nausea—Gemcitabine—hematologic cancer	2.95e-05	8.37e-05	CcSEcCtD
Eszopiclone—Vomiting—Cisplatin—hematologic cancer	2.95e-05	8.35e-05	CcSEcCtD
Eszopiclone—Hyperhidrosis—Prednisone—hematologic cancer	2.94e-05	8.33e-05	CcSEcCtD
Eszopiclone—Vision blurred—Methotrexate—hematologic cancer	2.94e-05	8.32e-05	CcSEcCtD
Eszopiclone—Erythema multiforme—Doxorubicin—hematologic cancer	2.93e-05	8.3e-05	CcSEcCtD
Eszopiclone—Rash—Cisplatin—hematologic cancer	2.92e-05	8.28e-05	CcSEcCtD
Eszopiclone—Dermatitis—Cisplatin—hematologic cancer	2.92e-05	8.27e-05	CcSEcCtD
Eszopiclone—Diarrhoea—Etoposide—hematologic cancer	2.9e-05	8.23e-05	CcSEcCtD
Eszopiclone—Anorexia—Prednisone—hematologic cancer	2.9e-05	8.22e-05	CcSEcCtD
Eszopiclone—Ill-defined disorder—Methotrexate—hematologic cancer	2.89e-05	8.19e-05	CcSEcCtD
Eszopiclone—Tinnitus—Doxorubicin—hematologic cancer	2.89e-05	8.19e-05	CcSEcCtD
Eszopiclone—Anaemia—Methotrexate—hematologic cancer	2.88e-05	8.16e-05	CcSEcCtD
Eszopiclone—Feeling abnormal—Betamethasone—hematologic cancer	2.88e-05	8.16e-05	CcSEcCtD
Eszopiclone—Feeling abnormal—Dexamethasone—hematologic cancer	2.88e-05	8.16e-05	CcSEcCtD
Eszopiclone—Tension—Epirubicin—hematologic cancer	2.86e-05	8.11e-05	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Betamethasone—hematologic cancer	2.86e-05	8.09e-05	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.86e-05	8.09e-05	CcSEcCtD
Eszopiclone—Dysgeusia—Epirubicin—hematologic cancer	2.86e-05	8.09e-05	CcSEcCtD
Eszopiclone—Hypersensitivity—Triamcinolone—hematologic cancer	2.84e-05	8.04e-05	CcSEcCtD
Eszopiclone—Nervousness—Epirubicin—hematologic cancer	2.83e-05	8.02e-05	CcSEcCtD
Eszopiclone—Back pain—Epirubicin—hematologic cancer	2.82e-05	7.99e-05	CcSEcCtD
Eszopiclone—Malaise—Methotrexate—hematologic cancer	2.81e-05	7.96e-05	CcSEcCtD
Eszopiclone—Dizziness—Etoposide—hematologic cancer	2.81e-05	7.95e-05	CcSEcCtD
Eszopiclone—Muscle spasms—Epirubicin—hematologic cancer	2.8e-05	7.94e-05	CcSEcCtD
Eszopiclone—Vertigo—Methotrexate—hematologic cancer	2.8e-05	7.93e-05	CcSEcCtD
Eszopiclone—Chills—Doxorubicin—hematologic cancer	2.78e-05	7.88e-05	CcSEcCtD
Eszopiclone—Urticaria—Betamethasone—hematologic cancer	2.78e-05	7.86e-05	CcSEcCtD
Eszopiclone—Urticaria—Dexamethasone—hematologic cancer	2.78e-05	7.86e-05	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.77e-05	7.85e-05	CcSEcCtD
Eszopiclone—Dizziness—Prednisolone—hematologic cancer	2.77e-05	7.84e-05	CcSEcCtD
Eszopiclone—Asthenia—Triamcinolone—hematologic cancer	2.76e-05	7.83e-05	CcSEcCtD
Eszopiclone—Abdominal pain—Dexamethasone—hematologic cancer	2.76e-05	7.82e-05	CcSEcCtD
Eszopiclone—Abdominal pain—Betamethasone—hematologic cancer	2.76e-05	7.82e-05	CcSEcCtD
Eszopiclone—Body temperature increased—Betamethasone—hematologic cancer	2.76e-05	7.82e-05	CcSEcCtD
Eszopiclone—Body temperature increased—Dexamethasone—hematologic cancer	2.76e-05	7.82e-05	CcSEcCtD
Eszopiclone—Nausea—Cisplatin—hematologic cancer	2.75e-05	7.8e-05	CcSEcCtD
Eszopiclone—Insomnia—Prednisone—hematologic cancer	2.75e-05	7.8e-05	CcSEcCtD
Eszopiclone—Vision blurred—Epirubicin—hematologic cancer	2.75e-05	7.78e-05	CcSEcCtD
Eszopiclone—Alopecia—Doxorubicin—hematologic cancer	2.74e-05	7.76e-05	CcSEcCtD
Eszopiclone—Paraesthesia—Prednisone—hematologic cancer	2.73e-05	7.74e-05	CcSEcCtD
Eszopiclone—Pruritus—Triamcinolone—hematologic cancer	2.72e-05	7.72e-05	CcSEcCtD
Eszopiclone—Ill-defined disorder—Epirubicin—hematologic cancer	2.71e-05	7.66e-05	CcSEcCtD
Eszopiclone—Convulsion—Methotrexate—hematologic cancer	2.7e-05	7.65e-05	CcSEcCtD
Eszopiclone—Vomiting—Etoposide—hematologic cancer	2.7e-05	7.65e-05	CcSEcCtD
Eszopiclone—Anaemia—Epirubicin—hematologic cancer	2.7e-05	7.63e-05	CcSEcCtD
Eszopiclone—Agitation—Epirubicin—hematologic cancer	2.68e-05	7.59e-05	CcSEcCtD
Eszopiclone—Dyspepsia—Prednisone—hematologic cancer	2.68e-05	7.59e-05	CcSEcCtD
Eszopiclone—Rash—Etoposide—hematologic cancer	2.68e-05	7.58e-05	CcSEcCtD
Eszopiclone—Dermatitis—Etoposide—hematologic cancer	2.67e-05	7.58e-05	CcSEcCtD
Eszopiclone—Headache—Etoposide—hematologic cancer	2.66e-05	7.53e-05	CcSEcCtD
Eszopiclone—Myalgia—Methotrexate—hematologic cancer	2.65e-05	7.51e-05	CcSEcCtD
Eszopiclone—Chest pain—Methotrexate—hematologic cancer	2.65e-05	7.51e-05	CcSEcCtD
Eszopiclone—Tension—Doxorubicin—hematologic cancer	2.65e-05	7.5e-05	CcSEcCtD
Eszopiclone—Decreased appetite—Prednisone—hematologic cancer	2.65e-05	7.49e-05	CcSEcCtD
Eszopiclone—Dysgeusia—Doxorubicin—hematologic cancer	2.64e-05	7.48e-05	CcSEcCtD
Eszopiclone—Rash—Prednisolone—hematologic cancer	2.64e-05	7.48e-05	CcSEcCtD
Eszopiclone—Dermatitis—Prednisolone—hematologic cancer	2.64e-05	7.47e-05	CcSEcCtD
Eszopiclone—Malaise—Epirubicin—hematologic cancer	2.63e-05	7.45e-05	CcSEcCtD
Eszopiclone—Fatigue—Prednisone—hematologic cancer	2.62e-05	7.43e-05	CcSEcCtD
Eszopiclone—Headache—Prednisolone—hematologic cancer	2.62e-05	7.43e-05	CcSEcCtD
Eszopiclone—Discomfort—Methotrexate—hematologic cancer	2.62e-05	7.42e-05	CcSEcCtD
Eszopiclone—Nervousness—Doxorubicin—hematologic cancer	2.62e-05	7.42e-05	CcSEcCtD
Eszopiclone—Vertigo—Epirubicin—hematologic cancer	2.62e-05	7.42e-05	CcSEcCtD
Eszopiclone—Back pain—Doxorubicin—hematologic cancer	2.61e-05	7.39e-05	CcSEcCtD
Eszopiclone—Constipation—Prednisone—hematologic cancer	2.6e-05	7.37e-05	CcSEcCtD
Eszopiclone—Muscle spasms—Doxorubicin—hematologic cancer	2.59e-05	7.35e-05	CcSEcCtD
Eszopiclone—Palpitations—Epirubicin—hematologic cancer	2.58e-05	7.3e-05	CcSEcCtD
Eszopiclone—Confusional state—Methotrexate—hematologic cancer	2.56e-05	7.26e-05	CcSEcCtD
Eszopiclone—Dizziness—Triamcinolone—hematologic cancer	2.55e-05	7.21e-05	CcSEcCtD
Eszopiclone—Anaphylactic shock—Methotrexate—hematologic cancer	2.54e-05	7.2e-05	CcSEcCtD
Eszopiclone—Vision blurred—Doxorubicin—hematologic cancer	2.54e-05	7.2e-05	CcSEcCtD
Eszopiclone—Convulsion—Epirubicin—hematologic cancer	2.53e-05	7.16e-05	CcSEcCtD
Eszopiclone—Infection—Methotrexate—hematologic cancer	2.53e-05	7.16e-05	CcSEcCtD
Eszopiclone—Nausea—Etoposide—hematologic cancer	2.52e-05	7.14e-05	CcSEcCtD
Eszopiclone—Hypertension—Epirubicin—hematologic cancer	2.52e-05	7.13e-05	CcSEcCtD
Eszopiclone—Feeling abnormal—Prednisone—hematologic cancer	2.51e-05	7.1e-05	CcSEcCtD
Eszopiclone—Asthenia—Dexamethasone—hematologic cancer	2.51e-05	7.1e-05	CcSEcCtD
Eszopiclone—Asthenia—Betamethasone—hematologic cancer	2.51e-05	7.1e-05	CcSEcCtD
Eszopiclone—Ill-defined disorder—Doxorubicin—hematologic cancer	2.5e-05	7.09e-05	CcSEcCtD
Eszopiclone—Anaemia—Doxorubicin—hematologic cancer	2.49e-05	7.06e-05	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Prednisone—hematologic cancer	2.49e-05	7.05e-05	CcSEcCtD
Eszopiclone—Nausea—Prednisolone—hematologic cancer	2.49e-05	7.05e-05	CcSEcCtD
Eszopiclone—Chest pain—Epirubicin—hematologic cancer	2.48e-05	7.03e-05	CcSEcCtD
Eszopiclone—Myalgia—Epirubicin—hematologic cancer	2.48e-05	7.03e-05	CcSEcCtD
Eszopiclone—Agitation—Doxorubicin—hematologic cancer	2.48e-05	7.02e-05	CcSEcCtD
Eszopiclone—Anxiety—Epirubicin—hematologic cancer	2.47e-05	7.01e-05	CcSEcCtD
Eszopiclone—Pruritus—Dexamethasone—hematologic cancer	2.47e-05	7e-05	CcSEcCtD
Eszopiclone—Pruritus—Betamethasone—hematologic cancer	2.47e-05	7e-05	CcSEcCtD
Eszopiclone—Hyperhidrosis—Methotrexate—hematologic cancer	2.46e-05	6.96e-05	CcSEcCtD
Eszopiclone—Discomfort—Epirubicin—hematologic cancer	2.45e-05	6.95e-05	CcSEcCtD
Eszopiclone—Vomiting—Triamcinolone—hematologic cancer	2.45e-05	6.94e-05	CcSEcCtD
Eszopiclone—Malaise—Doxorubicin—hematologic cancer	2.43e-05	6.89e-05	CcSEcCtD
Eszopiclone—Rash—Triamcinolone—hematologic cancer	2.43e-05	6.88e-05	CcSEcCtD
Eszopiclone—Dry mouth—Epirubicin—hematologic cancer	2.43e-05	6.88e-05	CcSEcCtD
Eszopiclone—Dermatitis—Triamcinolone—hematologic cancer	2.43e-05	6.87e-05	CcSEcCtD
Eszopiclone—Vertigo—Doxorubicin—hematologic cancer	2.42e-05	6.87e-05	CcSEcCtD
Eszopiclone—Anorexia—Methotrexate—hematologic cancer	2.42e-05	6.87e-05	CcSEcCtD
Eszopiclone—Urticaria—Prednisone—hematologic cancer	2.42e-05	6.85e-05	CcSEcCtD
Eszopiclone—Headache—Triamcinolone—hematologic cancer	2.41e-05	6.83e-05	CcSEcCtD
Eszopiclone—Abdominal pain—Prednisone—hematologic cancer	2.41e-05	6.81e-05	CcSEcCtD
Eszopiclone—Body temperature increased—Prednisone—hematologic cancer	2.41e-05	6.81e-05	CcSEcCtD
Eszopiclone—Confusional state—Epirubicin—hematologic cancer	2.4e-05	6.8e-05	CcSEcCtD
Eszopiclone—Diarrhoea—Dexamethasone—hematologic cancer	2.39e-05	6.77e-05	CcSEcCtD
Eszopiclone—Diarrhoea—Betamethasone—hematologic cancer	2.39e-05	6.77e-05	CcSEcCtD
Eszopiclone—Palpitations—Doxorubicin—hematologic cancer	2.38e-05	6.75e-05	CcSEcCtD
Eszopiclone—Anaphylactic shock—Epirubicin—hematologic cancer	2.38e-05	6.74e-05	CcSEcCtD
Eszopiclone—Infection—Epirubicin—hematologic cancer	2.36e-05	6.7e-05	CcSEcCtD
Eszopiclone—Convulsion—Doxorubicin—hematologic cancer	2.34e-05	6.62e-05	CcSEcCtD
Eszopiclone—Hypertension—Doxorubicin—hematologic cancer	2.33e-05	6.6e-05	CcSEcCtD
Eszopiclone—Tachycardia—Epirubicin—hematologic cancer	2.32e-05	6.58e-05	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.32e-05	6.56e-05	CcSEcCtD
Eszopiclone—Dizziness—Betamethasone—hematologic cancer	2.31e-05	6.54e-05	CcSEcCtD
Eszopiclone—Dizziness—Dexamethasone—hematologic cancer	2.31e-05	6.54e-05	CcSEcCtD
Eszopiclone—Hyperhidrosis—Epirubicin—hematologic cancer	2.3e-05	6.52e-05	CcSEcCtD
Eszopiclone—Insomnia—Methotrexate—hematologic cancer	2.3e-05	6.51e-05	CcSEcCtD
Eszopiclone—Chest pain—Doxorubicin—hematologic cancer	2.3e-05	6.51e-05	CcSEcCtD
Eszopiclone—Myalgia—Doxorubicin—hematologic cancer	2.3e-05	6.51e-05	CcSEcCtD
Eszopiclone—Anxiety—Doxorubicin—hematologic cancer	2.29e-05	6.48e-05	CcSEcCtD
Eszopiclone—Nausea—Triamcinolone—hematologic cancer	2.29e-05	6.48e-05	CcSEcCtD
Eszopiclone—Paraesthesia—Methotrexate—hematologic cancer	2.28e-05	6.47e-05	CcSEcCtD
Eszopiclone—Discomfort—Doxorubicin—hematologic cancer	2.27e-05	6.43e-05	CcSEcCtD
Eszopiclone—Anorexia—Epirubicin—hematologic cancer	2.27e-05	6.43e-05	CcSEcCtD
Eszopiclone—Dyspnoea—Methotrexate—hematologic cancer	2.27e-05	6.42e-05	CcSEcCtD
Eszopiclone—Somnolence—Methotrexate—hematologic cancer	2.26e-05	6.4e-05	CcSEcCtD
Eszopiclone—Dry mouth—Doxorubicin—hematologic cancer	2.25e-05	6.36e-05	CcSEcCtD
Eszopiclone—Hypersensitivity—Prednisone—hematologic cancer	2.24e-05	6.35e-05	CcSEcCtD
Eszopiclone—Dyspepsia—Methotrexate—hematologic cancer	2.24e-05	6.34e-05	CcSEcCtD
Eszopiclone—Vomiting—Dexamethasone—hematologic cancer	2.22e-05	6.29e-05	CcSEcCtD
Eszopiclone—Vomiting—Betamethasone—hematologic cancer	2.22e-05	6.29e-05	CcSEcCtD
Eszopiclone—Confusional state—Doxorubicin—hematologic cancer	2.22e-05	6.29e-05	CcSEcCtD
Eszopiclone—Decreased appetite—Methotrexate—hematologic cancer	2.21e-05	6.26e-05	CcSEcCtD
Eszopiclone—Rash—Betamethasone—hematologic cancer	2.2e-05	6.24e-05	CcSEcCtD
Eszopiclone—Rash—Dexamethasone—hematologic cancer	2.2e-05	6.24e-05	CcSEcCtD
Eszopiclone—Anaphylactic shock—Doxorubicin—hematologic cancer	2.2e-05	6.24e-05	CcSEcCtD
Eszopiclone—Dermatitis—Dexamethasone—hematologic cancer	2.2e-05	6.23e-05	CcSEcCtD
Eszopiclone—Dermatitis—Betamethasone—hematologic cancer	2.2e-05	6.23e-05	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.2e-05	6.22e-05	CcSEcCtD
Eszopiclone—Fatigue—Methotrexate—hematologic cancer	2.19e-05	6.21e-05	CcSEcCtD
Eszopiclone—Headache—Betamethasone—hematologic cancer	2.19e-05	6.2e-05	CcSEcCtD
Eszopiclone—Headache—Dexamethasone—hematologic cancer	2.19e-05	6.2e-05	CcSEcCtD
Eszopiclone—Infection—Doxorubicin—hematologic cancer	2.19e-05	6.2e-05	CcSEcCtD
Eszopiclone—Asthenia—Prednisone—hematologic cancer	2.18e-05	6.18e-05	CcSEcCtD
Eszopiclone—Pain—Methotrexate—hematologic cancer	2.17e-05	6.16e-05	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.17e-05	6.14e-05	CcSEcCtD
Eszopiclone—Pruritus—Prednisone—hematologic cancer	2.15e-05	6.1e-05	CcSEcCtD
Eszopiclone—Insomnia—Epirubicin—hematologic cancer	2.15e-05	6.1e-05	CcSEcCtD
Eszopiclone—Tachycardia—Doxorubicin—hematologic cancer	2.15e-05	6.09e-05	CcSEcCtD
Eszopiclone—Paraesthesia—Epirubicin—hematologic cancer	2.14e-05	6.05e-05	CcSEcCtD
Eszopiclone—Hyperhidrosis—Doxorubicin—hematologic cancer	2.13e-05	6.03e-05	CcSEcCtD
Eszopiclone—Dyspnoea—Epirubicin—hematologic cancer	2.12e-05	6.01e-05	CcSEcCtD
Eszopiclone—Somnolence—Epirubicin—hematologic cancer	2.12e-05	5.99e-05	CcSEcCtD
Eszopiclone—Anorexia—Doxorubicin—hematologic cancer	2.1e-05	5.95e-05	CcSEcCtD
Eszopiclone—Feeling abnormal—Methotrexate—hematologic cancer	2.1e-05	5.94e-05	CcSEcCtD
Eszopiclone—Dyspepsia—Epirubicin—hematologic cancer	2.09e-05	5.93e-05	CcSEcCtD
Eszopiclone—Diarrhoea—Prednisone—hematologic cancer	2.08e-05	5.9e-05	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Methotrexate—hematologic cancer	2.08e-05	5.89e-05	CcSEcCtD
Eszopiclone—Nausea—Dexamethasone—hematologic cancer	2.08e-05	5.88e-05	CcSEcCtD
Eszopiclone—Nausea—Betamethasone—hematologic cancer	2.08e-05	5.88e-05	CcSEcCtD
Eszopiclone—Decreased appetite—Epirubicin—hematologic cancer	2.07e-05	5.86e-05	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.05e-05	5.82e-05	CcSEcCtD
Eszopiclone—Fatigue—Epirubicin—hematologic cancer	2.05e-05	5.81e-05	CcSEcCtD
Eszopiclone—Pain—Epirubicin—hematologic cancer	2.04e-05	5.76e-05	CcSEcCtD
Eszopiclone—Constipation—Epirubicin—hematologic cancer	2.04e-05	5.76e-05	CcSEcCtD
Eszopiclone—Urticaria—Methotrexate—hematologic cancer	2.02e-05	5.72e-05	CcSEcCtD
Eszopiclone—Dizziness—Prednisone—hematologic cancer	2.01e-05	5.7e-05	CcSEcCtD
Eszopiclone—Abdominal pain—Methotrexate—hematologic cancer	2.01e-05	5.69e-05	CcSEcCtD
Eszopiclone—Body temperature increased—Methotrexate—hematologic cancer	2.01e-05	5.69e-05	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.01e-05	5.68e-05	CcSEcCtD
Eszopiclone—Insomnia—Doxorubicin—hematologic cancer	1.99e-05	5.64e-05	CcSEcCtD
Eszopiclone—Paraesthesia—Doxorubicin—hematologic cancer	1.98e-05	5.6e-05	CcSEcCtD
Eszopiclone—Dyspnoea—Doxorubicin—hematologic cancer	1.96e-05	5.56e-05	CcSEcCtD
Eszopiclone—Feeling abnormal—Epirubicin—hematologic cancer	1.96e-05	5.55e-05	CcSEcCtD
Eszopiclone—Somnolence—Doxorubicin—hematologic cancer	1.96e-05	5.54e-05	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.95e-05	5.51e-05	CcSEcCtD
Eszopiclone—Dyspepsia—Doxorubicin—hematologic cancer	1.94e-05	5.49e-05	CcSEcCtD
Eszopiclone—Vomiting—Prednisone—hematologic cancer	1.93e-05	5.48e-05	CcSEcCtD
Eszopiclone—Rash—Prednisone—hematologic cancer	1.92e-05	5.43e-05	CcSEcCtD
Eszopiclone—Dermatitis—Prednisone—hematologic cancer	1.92e-05	5.43e-05	CcSEcCtD
Eszopiclone—Decreased appetite—Doxorubicin—hematologic cancer	1.91e-05	5.42e-05	CcSEcCtD
Eszopiclone—Headache—Prednisone—hematologic cancer	1.91e-05	5.4e-05	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.9e-05	5.38e-05	CcSEcCtD
Eszopiclone—Fatigue—Doxorubicin—hematologic cancer	1.9e-05	5.38e-05	CcSEcCtD
Eszopiclone—Urticaria—Epirubicin—hematologic cancer	1.89e-05	5.36e-05	CcSEcCtD
Eszopiclone—Pain—Doxorubicin—hematologic cancer	1.88e-05	5.33e-05	CcSEcCtD
Eszopiclone—Constipation—Doxorubicin—hematologic cancer	1.88e-05	5.33e-05	CcSEcCtD
Eszopiclone—Abdominal pain—Epirubicin—hematologic cancer	1.88e-05	5.33e-05	CcSEcCtD
Eszopiclone—Body temperature increased—Epirubicin—hematologic cancer	1.88e-05	5.33e-05	CcSEcCtD
Eszopiclone—Hypersensitivity—Methotrexate—hematologic cancer	1.87e-05	5.31e-05	CcSEcCtD
Eszopiclone—Asthenia—Methotrexate—hematologic cancer	1.82e-05	5.17e-05	CcSEcCtD
Eszopiclone—Feeling abnormal—Doxorubicin—hematologic cancer	1.81e-05	5.14e-05	CcSEcCtD
Eszopiclone—Nausea—Prednisone—hematologic cancer	1.81e-05	5.12e-05	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.8e-05	5.1e-05	CcSEcCtD
Eszopiclone—Pruritus—Methotrexate—hematologic cancer	1.8e-05	5.1e-05	CcSEcCtD
Eszopiclone—Hypersensitivity—Epirubicin—hematologic cancer	1.75e-05	4.97e-05	CcSEcCtD
Eszopiclone—Urticaria—Doxorubicin—hematologic cancer	1.75e-05	4.95e-05	CcSEcCtD
Eszopiclone—Body temperature increased—Doxorubicin—hematologic cancer	1.74e-05	4.93e-05	CcSEcCtD
Eszopiclone—Abdominal pain—Doxorubicin—hematologic cancer	1.74e-05	4.93e-05	CcSEcCtD
Eszopiclone—Diarrhoea—Methotrexate—hematologic cancer	1.74e-05	4.93e-05	CcSEcCtD
Eszopiclone—Asthenia—Epirubicin—hematologic cancer	1.71e-05	4.84e-05	CcSEcCtD
Eszopiclone—Pruritus—Epirubicin—hematologic cancer	1.68e-05	4.77e-05	CcSEcCtD
Eszopiclone—Dizziness—Methotrexate—hematologic cancer	1.68e-05	4.76e-05	CcSEcCtD
Eszopiclone—Diarrhoea—Epirubicin—hematologic cancer	1.63e-05	4.61e-05	CcSEcCtD
Eszopiclone—Hypersensitivity—Doxorubicin—hematologic cancer	1.62e-05	4.6e-05	CcSEcCtD
Eszopiclone—Vomiting—Methotrexate—hematologic cancer	1.62e-05	4.58e-05	CcSEcCtD
Eszopiclone—Rash—Methotrexate—hematologic cancer	1.6e-05	4.54e-05	CcSEcCtD
Eszopiclone—Dermatitis—Methotrexate—hematologic cancer	1.6e-05	4.54e-05	CcSEcCtD
Eszopiclone—Headache—Methotrexate—hematologic cancer	1.59e-05	4.51e-05	CcSEcCtD
Eszopiclone—Asthenia—Doxorubicin—hematologic cancer	1.58e-05	4.48e-05	CcSEcCtD
Eszopiclone—Dizziness—Epirubicin—hematologic cancer	1.57e-05	4.46e-05	CcSEcCtD
Eszopiclone—Pruritus—Doxorubicin—hematologic cancer	1.56e-05	4.41e-05	CcSEcCtD
Eszopiclone—Vomiting—Epirubicin—hematologic cancer	1.51e-05	4.29e-05	CcSEcCtD
Eszopiclone—Nausea—Methotrexate—hematologic cancer	1.51e-05	4.28e-05	CcSEcCtD
Eszopiclone—Diarrhoea—Doxorubicin—hematologic cancer	1.51e-05	4.27e-05	CcSEcCtD
Eszopiclone—Rash—Epirubicin—hematologic cancer	1.5e-05	4.25e-05	CcSEcCtD
Eszopiclone—Dermatitis—Epirubicin—hematologic cancer	1.5e-05	4.25e-05	CcSEcCtD
Eszopiclone—Headache—Epirubicin—hematologic cancer	1.49e-05	4.22e-05	CcSEcCtD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.46e-05	0.000273	CbGpPWpGaD
Eszopiclone—Dizziness—Doxorubicin—hematologic cancer	1.46e-05	4.12e-05	CcSEcCtD
Eszopiclone—CYP2C9—Metabolism—B3GAT1—hematologic cancer	1.45e-05	0.000271	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—DCK—hematologic cancer	1.45e-05	0.000271	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ASNS—hematologic cancer	1.45e-05	0.000271	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—IDH1—hematologic cancer	1.45e-05	0.000271	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GBA—hematologic cancer	1.44e-05	0.000269	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC35B2—hematologic cancer	1.44e-05	0.000269	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.44e-05	0.000268	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—TXN—hematologic cancer	1.44e-05	0.000268	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTO1—hematologic cancer	1.44e-05	0.000268	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ABCC3—hematologic cancer	1.44e-05	0.000268	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.42e-05	0.000265	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.42e-05	0.000265	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.42e-05	0.000265	CbGpPWpGaD
Eszopiclone—Nausea—Epirubicin—hematologic cancer	1.41e-05	4e-05	CcSEcCtD
Eszopiclone—PTGS1—Metabolism—SPHK1—hematologic cancer	1.41e-05	0.000262	CbGpPWpGaD
Eszopiclone—Vomiting—Doxorubicin—hematologic cancer	1.4e-05	3.97e-05	CcSEcCtD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.4e-05	0.000261	CbGpPWpGaD
Eszopiclone—Rash—Doxorubicin—hematologic cancer	1.39e-05	3.93e-05	CcSEcCtD
Eszopiclone—GABRA4—Neuronal System—HRAS—hematologic cancer	1.39e-05	0.000259	CbGpPWpGaD
Eszopiclone—Dermatitis—Doxorubicin—hematologic cancer	1.39e-05	3.93e-05	CcSEcCtD
Eszopiclone—Headache—Doxorubicin—hematologic cancer	1.38e-05	3.91e-05	CcSEcCtD
Eszopiclone—CYP2C9—Metabolism—HDC—hematologic cancer	1.38e-05	0.000257	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.37e-05	0.000256	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.37e-05	0.000256	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—UGT1A1—hematologic cancer	1.35e-05	0.000252	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.34e-05	0.00025	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—ALB—hematologic cancer	1.33e-05	0.000248	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.32e-05	0.000247	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MTAP—hematologic cancer	1.32e-05	0.000246	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SLC22A1—hematologic cancer	1.31e-05	0.000245	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CRABP1—hematologic cancer	1.31e-05	0.000245	CbGpPWpGaD
Eszopiclone—Nausea—Doxorubicin—hematologic cancer	1.31e-05	3.7e-05	CcSEcCtD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.31e-05	0.000244	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.29e-05	0.00024	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.28e-05	0.00024	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ALOX5—hematologic cancer	1.28e-05	0.000239	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—HRAS—hematologic cancer	1.27e-05	0.000237	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CDA—hematologic cancer	1.26e-05	0.000235	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.25e-05	0.000234	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NUP98—hematologic cancer	1.24e-05	0.000231	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—HRAS—hematologic cancer	1.23e-05	0.00023	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PC—hematologic cancer	1.21e-05	0.000226	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—HRAS—hematologic cancer	1.21e-05	0.000226	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NCOA3—hematologic cancer	1.2e-05	0.000225	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ADCY7—hematologic cancer	1.2e-05	0.000225	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—FTCD—hematologic cancer	1.2e-05	0.000224	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PHYH—hematologic cancer	1.2e-05	0.000224	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GMPS—hematologic cancer	1.2e-05	0.000224	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NUP214—hematologic cancer	1.2e-05	0.000223	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—HRAS—hematologic cancer	1.19e-05	0.000222	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.18e-05	0.000221	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—FHL2—hematologic cancer	1.17e-05	0.000219	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GBA—hematologic cancer	1.17e-05	0.000219	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1.17e-05	0.000219	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ABCG2—hematologic cancer	1.17e-05	0.000219	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—MTR—hematologic cancer	1.17e-05	0.000219	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.17e-05	0.000218	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—HRAS—hematologic cancer	1.16e-05	0.000217	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—AGRN—hematologic cancer	1.15e-05	0.000215	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ENO2—hematologic cancer	1.15e-05	0.000214	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTT1—hematologic cancer	1.11e-05	0.000208	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.1e-05	0.000205	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.1e-05	0.000205	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.1e-05	0.000204	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HMMR—hematologic cancer	1.09e-05	0.000204	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—IDH2—hematologic cancer	1.09e-05	0.000204	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SDC1—hematologic cancer	1.09e-05	0.000203	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MTAP—hematologic cancer	1.07e-05	0.0002	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.04e-05	0.000194	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.03e-05	0.000192	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.03e-05	0.000192	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ARNTL—hematologic cancer	1.03e-05	0.000191	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—HRAS—hematologic cancer	1.01e-05	0.000189	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ACP5—hematologic cancer	9.99e-06	0.000186	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CA9—hematologic cancer	9.99e-06	0.000186	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NCOR2—hematologic cancer	9.85e-06	0.000184	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.82e-06	0.000183	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—B3GAT1—hematologic cancer	9.59e-06	0.000179	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—DCK—hematologic cancer	9.59e-06	0.000179	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ASNS—hematologic cancer	9.59e-06	0.000179	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—FHL2—hematologic cancer	9.56e-06	0.000178	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—IDH1—hematologic cancer	9.39e-06	0.000175	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—AGRN—hematologic cancer	9.37e-06	0.000175	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTO1—hematologic cancer	9.28e-06	0.000173	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ABCC3—hematologic cancer	9.28e-06	0.000173	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—TXN—hematologic cancer	9.28e-06	0.000173	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CD44—hematologic cancer	9.26e-06	0.000173	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NQO1—hematologic cancer	9.26e-06	0.000173	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HDC—hematologic cancer	9.09e-06	0.00017	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SPHK1—hematologic cancer	9.08e-06	0.000169	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.07e-06	0.000169	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HMMR—hematologic cancer	8.89e-06	0.000166	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—IDH2—hematologic cancer	8.89e-06	0.000166	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYCS—hematologic cancer	8.76e-06	0.000163	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—UGT1A1—hematologic cancer	8.73e-06	0.000163	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—HSP90AA1—hematologic cancer	8.71e-06	0.000162	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CRABP1—hematologic cancer	8.49e-06	0.000158	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC22A1—hematologic cancer	8.49e-06	0.000158	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.38e-06	0.000156	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ARNTL—hematologic cancer	8.35e-06	0.000156	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CDA—hematologic cancer	8.32e-06	0.000155	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ALOX5—hematologic cancer	8.27e-06	0.000154	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ACP5—hematologic cancer	8.13e-06	0.000152	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CA9—hematologic cancer	8.13e-06	0.000152	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NCOR2—hematologic cancer	8.02e-06	0.00015	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NUP98—hematologic cancer	8.01e-06	0.000149	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PC—hematologic cancer	8.01e-06	0.000149	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.84e-06	0.000146	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ADCY7—hematologic cancer	7.78e-06	0.000145	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NCOA3—hematologic cancer	7.78e-06	0.000145	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GBA—hematologic cancer	7.73e-06	0.000144	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.73e-06	0.000144	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NUP214—hematologic cancer	7.72e-06	0.000144	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTP1—hematologic cancer	7.72e-06	0.000144	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.64e-06	0.000143	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—IDH1—hematologic cancer	7.64e-06	0.000143	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MTR—hematologic cancer	7.57e-06	0.000141	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ABCG2—hematologic cancer	7.57e-06	0.000141	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—TXN—hematologic cancer	7.55e-06	0.000141	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTO1—hematologic cancer	7.55e-06	0.000141	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ABCC3—hematologic cancer	7.55e-06	0.000141	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.47e-06	0.000139	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ENO2—hematologic cancer	7.42e-06	0.000138	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SPHK1—hematologic cancer	7.39e-06	0.000138	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ABCB1—hematologic cancer	7.31e-06	0.000136	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTT1—hematologic cancer	7.2e-06	0.000134	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—UGT1A1—hematologic cancer	7.1e-06	0.000132	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTM1—hematologic cancer	7.1e-06	0.000132	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NCOR1—hematologic cancer	7.1e-06	0.000132	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.09e-06	0.000132	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MTAP—hematologic cancer	7.07e-06	0.000132	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SDC1—hematologic cancer	7.03e-06	0.000131	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC22A1—hematologic cancer	6.91e-06	0.000129	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CRABP1—hematologic cancer	6.91e-06	0.000129	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ALOX5—hematologic cancer	6.73e-06	0.000126	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.72e-06	0.000125	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.63e-06	0.000124	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NUP98—hematologic cancer	6.52e-06	0.000122	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.35e-06	0.000118	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ADCY7—hematologic cancer	6.33e-06	0.000118	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NCOA3—hematologic cancer	6.33e-06	0.000118	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—FHL2—hematologic cancer	6.3e-06	0.000118	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NUP214—hematologic cancer	6.29e-06	0.000117	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—MTHFR—hematologic cancer	6.27e-06	0.000117	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.22e-06	0.000116	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—AGRN—hematologic cancer	6.18e-06	0.000115	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MTR—hematologic cancer	6.16e-06	0.000115	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ABCG2—hematologic cancer	6.16e-06	0.000115	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ENO2—hematologic cancer	6.04e-06	0.000113	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NQO1—hematologic cancer	5.98e-06	0.000112	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CD44—hematologic cancer	5.98e-06	0.000112	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—IDH2—hematologic cancer	5.86e-06	0.000109	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HMMR—hematologic cancer	5.86e-06	0.000109	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.86e-06	0.000109	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.86e-06	0.000109	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.77e-06	0.000108	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SDC1—hematologic cancer	5.73e-06	0.000107	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYCS—hematologic cancer	5.66e-06	0.000106	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	5.62e-06	0.000105	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.53e-06	0.000103	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.51e-06	0.000103	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.47e-06	0.000102	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.4e-06	0.000101	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ACP5—hematologic cancer	5.36e-06	0.0001	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CA9—hematologic cancer	5.36e-06	0.0001	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.29e-06	9.87e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CG—hematologic cancer	5.27e-06	9.83e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.16e-06	9.63e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.06e-06	9.44e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—IDH1—hematologic cancer	5.04e-06	9.4e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.99e-06	9.31e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—TXN—hematologic cancer	4.98e-06	9.29e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.98e-06	9.29e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.98e-06	9.29e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CREBBP—hematologic cancer	4.89e-06	9.11e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.88e-06	9.1e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NQO1—hematologic cancer	4.87e-06	9.08e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CD44—hematologic cancer	4.87e-06	9.08e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.83e-06	9e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.77e-06	8.89e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.72e-06	8.81e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.68e-06	8.74e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CD—hematologic cancer	4.63e-06	8.64e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYCS—hematologic cancer	4.61e-06	8.59e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NCOR1—hematologic cancer	4.58e-06	8.55e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTM1—hematologic cancer	4.58e-06	8.55e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.58e-06	8.54e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ALB—hematologic cancer	4.57e-06	8.53e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.56e-06	8.5e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.56e-06	8.5e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.44e-06	8.28e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3R1—hematologic cancer	4.38e-06	8.16e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NUP98—hematologic cancer	4.3e-06	8.02e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.18e-06	7.79e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.18e-06	7.79e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NUP214—hematologic cancer	4.15e-06	7.73e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.12e-06	7.68e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.06e-06	7.58e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MTR—hematologic cancer	4.06e-06	7.58e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.06e-06	7.57e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MTHFR—hematologic cancer	4.05e-06	7.56e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CB—hematologic cancer	4.04e-06	7.53e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ENO2—hematologic cancer	3.98e-06	7.43e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.93e-06	7.33e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.86e-06	7.21e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.84e-06	7.17e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SDC1—hematologic cancer	3.78e-06	7.04e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.73e-06	6.96e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.73e-06	6.96e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.57e-06	6.66e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PTEN—hematologic cancer	3.49e-06	6.51e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.4e-06	6.35e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—EP300—hematologic cancer	3.33e-06	6.21e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.3e-06	6.15e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NQO1—hematologic cancer	3.21e-06	5.99e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CD44—hematologic cancer	3.21e-06	5.99e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CREBBP—hematologic cancer	3.16e-06	5.89e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYCS—hematologic cancer	3.04e-06	5.67e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.02e-06	5.63e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.99e-06	5.58e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ALB—hematologic cancer	2.95e-06	5.51e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.91e-06	5.42e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.83e-06	5.27e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.77e-06	5.17e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.68e-06	5e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.61e-06	4.87e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.57e-06	4.79e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.53e-06	4.73e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CA—hematologic cancer	2.46e-06	4.59e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.46e-06	4.59e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.46e-06	4.59e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.44e-06	4.54e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ALB—hematologic cancer	2.4e-06	4.49e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.3e-06	4.29e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTEN—hematologic cancer	2.25e-06	4.2e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.17e-06	4.06e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—EP300—hematologic cancer	2.15e-06	4.01e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.12e-06	3.96e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—AKT1—hematologic cancer	2.01e-06	3.75e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTEN—hematologic cancer	1.83e-06	3.42e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.83e-06	3.41e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—EP300—hematologic cancer	1.75e-06	3.26e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.69e-06	3.16e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.61e-06	3e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.59e-06	2.97e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ALB—hematologic cancer	1.59e-06	2.96e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.52e-06	2.83e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.4e-06	2.61e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—AKT1—hematologic cancer	1.3e-06	2.42e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.29e-06	2.41e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTEN—hematologic cancer	1.21e-06	2.26e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—EP300—hematologic cancer	1.15e-06	2.15e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—AKT1—hematologic cancer	1.06e-06	1.97e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.54e-07	1.59e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—AKT1—hematologic cancer	6.97e-07	1.3e-05	CbGpPWpGaD
